{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:35:38Z","timestamp":1793745338166,"version":"4.6.1"},"reference-count":37,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Oncogenic mutations in Kirsten rat sarcoma virus are present in over 90% of pancreatic ductal adenocarcinomas (PDACs). Preclinical data suggest that PDAC cells treated with inhibitors of the mitogen-activated protein kinase pathway demonstrate elevated autophagic flux. In this study, we evaluate the clinical efficacy of combining LY3214996 (extracellular regulated kinase inhibitor) with hydroxychloroquine (HCQ; autophagy inhibitor) in patients with metastatic PDAC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Eligible patients had metastatic PDAC and at least one, but no more than two prior lines of systemic therapy. A safety lead-in evaluating the combination was conducted and the maximum tolerated dose level of LY3214996 was identified. Patients were then randomly assigned in a 1:1 fashion to receive either LY3214996 200 mg orally (PO) once daily + HCQ 600 mg PO twice a day (arm 1) or LY3214996 400 mg PO once daily (arm 2). The primary end point for this study was disease control rate (DCR). Secondary end points included overall survival (OS) and progression-free survival (PFS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Thirty-nine patients enrolled (20 in arm 1, 19 in arm 2). The DCR rates were 5% in arm 1 and 5.3% in arm 2. The median OS was 2.4 months in arm 1 (95% CI, 1.3 to 5.8) and 4.6 months in arm 2 (95% CI, 3.1 to 5.7). The median PFS was 1.3 months in arm 1 (95% CI, 0.8 to 1.8) and 1.9 months in arm 2 (95% CI, 1.644 to 2.4). The most frequently observed toxicities in both arms included nausea, diarrhea, elevated creatine phosphokinase, anorexia, and cytopenias. Exploratory analysis using patient-derived PDAC organoids did not show evidence of synergistic antiproliferative activity of LY3214996 in combination with chloroquine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>LY3214996 alone or in combination with HCQ did not result in clinical activity in patients with metastatic PDAC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/po-25-00332","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T19:59:32Z","timestamp":1756843172000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":8,"title":["Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-9236","authenticated-orcid":true,"given":"Rishi","family":"Surana","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-5812","authenticated-orcid":true,"given":"Micaela","family":"Morgado","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-406X","authenticated-orcid":true,"given":"Ashwin","family":"Somasundaram","sequence":"additional","affiliation":[{"name":"Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-1560","authenticated-orcid":true,"given":"Bruno","family":"Bockorny","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D.","family":"Weekes","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6010-9970","authenticated-orcid":true,"given":"Emma C.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bird","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-9343","authenticated-orcid":true,"given":"Junning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0434-3900","authenticated-orcid":true,"given":"Hannah L.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-1910","authenticated-orcid":true,"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-0407","authenticated-orcid":true,"given":"Lauren K.","family":"Brais","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-2397","authenticated-orcid":true,"given":"Neetu","family":"Saxena","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ritterband","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sawin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-7583","authenticated-orcid":true,"given":"Mary Linton","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Whooley","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-0225","authenticated-orcid":true,"given":"Andrea","family":"Bullock","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-4473","authenticated-orcid":true,"given":"Jessica","family":"Zerillo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-4486","authenticated-orcid":true,"given":"Hanna K.","family":"Sanoff","sequence":"additional","affiliation":[{"name":"Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-3600","authenticated-orcid":true,"given":"Jeffrey W.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-7841","authenticated-orcid":false,"given":"Aparna R.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-9273","authenticated-orcid":true,"given":"Matthew B.","family":"Yurgelun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-6957","authenticated-orcid":true,"given":"Anuj K.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-3951","authenticated-orcid":true,"given":"James M.","family":"Cleary","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Enzinger","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-5231","authenticated-orcid":true,"given":"Douglas A.","family":"Rubinson","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2377-8301","authenticated-orcid":true,"given":"Nadine J.","family":"McCleary","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7502-8081","authenticated-orcid":true,"given":"Andrea","family":"Enzinger","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0683-5436","authenticated-orcid":true,"given":"Sarah","family":"Slater","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-1494","authenticated-orcid":true,"given":"Kimmie","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-7121","authenticated-orcid":true,"given":"Leah H.","family":"Biller","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3101-1573","authenticated-orcid":true,"given":"Thomas A.","family":"Abrams","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-3145","authenticated-orcid":true,"given":"Brandon M.","family":"Huffman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-2013","authenticated-orcid":true,"given":"Harshabad","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-9918","authenticated-orcid":true,"given":"Srivatsan","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Mancias","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-0942","authenticated-orcid":true,"given":"Kirsten L.","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-7407","authenticated-orcid":true,"given":"Jonathan O.","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"},{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-6203","authenticated-orcid":true,"given":"Andrew J.","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channing J.","family":"Der","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0455-1032","authenticated-orcid":true,"given":"Brian M.","family":"Wolpin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-2994","authenticated-orcid":true,"given":"Kimberly","family":"Perez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0275"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac237"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4956"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.10"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.185"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-011-9687-4"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31603"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2016111"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0952"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01039-5"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0086"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1817494116"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0367-9"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0368-8"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0184"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0177"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.11.017"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202208092"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.3001"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12016-z"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.711"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-111020-090812"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-4042"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.3086"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3178"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-1757"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","unstructured":"Cheng C Hu J Mannan R et al: Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer. bioRxiv 10.1101\/2024.03.18.585580","DOI":"10.1101\/2024.03.18.585580"},{"key":"e_1_3_7_29_2","first-page":"4119","article-title":"Phase 1 clinical safety, pharmacokinetics (PK), and activity of apilimod dimesylate (LAM-002A), a first-in-class inhibitor of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve), in patients with relapsed or refractory B-cell malignancies","volume":"130","author":"Harb WA","year":"2017","unstructured":"Harb WA, Diefenbach CS, Lakhani N, et al: Phase 1 clinical safety, pharmacokinetics (PK), and activity of apilimod dimesylate (LAM-002A), a first-in-class inhibitor of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve), in patients with relapsed or refractory B-cell malignancies. Blood 130:4119, 2017","journal-title":"Blood"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00237-1"},{"key":"e_1_3_7_31_2","first-page":"132","article-title":"\u201cUndruggable KRAS\u201d: Druggable after all","volume":"39","author":"Cox AD","year":"2025","unstructured":"Cox AD, Der CJ: \u201cUndruggable KRAS\u201d: Druggable after all. Genes Dev 39:132-162, 2025","journal-title":"Genes Dev"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0027"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114992"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.TPS845"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.724"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2098"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-526"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-23-B115"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T19:59:37Z","timestamp":1756843177000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1200\/PO-25-00332"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00332","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500332"}}